Aditi Soni

Aditi Soni is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting bone morphogenetic protein 6 (BMP6). With a total of 4 patents to her name, her work is paving the way for innovative treatments in various diseases.

Latest Patents

Among her latest patents are "Compositions and methods for antibodies targeting BMP6" and "Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)". The first patent focuses on antibodies and antigen-binding fragments that target human BMP6, along with the compositions and methods of use. The second patent outlines methods of treatment utilizing BMP6 antagonists, showcasing her commitment to advancing medical science.

Career Highlights

Aditi Soni is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

She has worked alongside notable colleagues such as Feng Cong and William Dietrich, further enhancing her research capabilities and expanding the impact of her inventions.

Conclusion

Aditi Soni's innovative work in antibody research and her contributions to the field of biotechnology exemplify her dedication to improving healthcare solutions. Her patents reflect a promising future for treatments targeting BMP6, and her collaborations with esteemed colleagues further amplify her impact in the scientific community.

Profile summary based on public USPTO records.